Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

BST2 is a key marker for hair loss disease alopecia areata.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Stem cell vesicles reduced eczema symptoms in mice safely.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Dandruff is linked to changes in the immune system of hair follicles and skin.

Immune cells help keep skin healthy and repair it, but imbalance can cause disease.

Enhancing immune response can improve cancer treatment effectiveness.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

3D cultures can create active macrophages from fat tissue.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Hair follicle stem cells can become nerve cells using specific treatments.

Targeting regulatory T cells may help treat age-related diseases.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.